Irish Heart FoundationHypertensioncardiovascular disease
…each programs can reach vulnerable populations ( figure 1). The Irish Heart Foundation’s Mobile Health Unit (MHU) offers free heart health checks to i…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 721–780 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
A NHS Trust1A2 Bio1A2 Biotherapeutics1AAALAC1AAALAC-accredited1AALAC1AAOS1AAP1AAPM1AAST1AAST International Relations Committee1ABF - Associated British Foods1ABN1ABN Clinical Research Training Fellowships1ACC1ACGME-I1ACIP1ACM Digital Library1ACOG1ACPMP1ACTRN126170002043471ACTRN126220013607071ACTRN12623000049673p1ACTRN126230001976391ACTRN126230003416281AFA1AIFA-CNS1ANR1ANZCTR1ANZCTR126180018312791AO3-E23-24B1APA1APM1ASA1ASHP1ASKgene pharm, Inc1ASL1ASRA Pain Medicine1AbbVie1AbbVie Inc1Abbott Laboratories1Aboriginal Health and Medical Research Council of New South Wales1Academic Search Complete1Active Plus1Administration for Strategic Preparedness and Response1Advanced Google1Advarra IRB1Advarra Institutional Review Board1Advisory Committee for Immunization Practices1Aetna1Afghan government1Africa Union1African Union1Agence National de Sécurité du Médicament1Agence Régionale de Santé Ile de France1Agencia Española de Medicamentos y Productos Sanitarios1Agency for Healthcare Research and Quality Evidence-based Practice Center Programme1Agenzia Italiana del Farmaco1Air Force1Alcohol Education Trust1
Articles mentioning funders
5,089 articles · page 357 of 425NICEMavacamtenSix-Minute Walk TestBelfast Inherited Cardiac Services CentreoHCMsymptomatic obstructive hypertrophic cardiomyopathy
…Mavacamten, a first-in-class cardiac myosin inhibitor, received NICE approval in September 2023 for adults with symptomatic obstruct…
Scopusacute myocardial infarctionAMI-CSpVADIABPcardiogenic shockVA-ECMO
…I-CS. We searched Medline, EMBASE, CENTRAL, Web of Science, and Scopus from inception to May 2024. We evaluated the effect of each int…
NHS Primary Care NetworksType 2 DiabetesMAFLDNDHNon-Diabetic HyperglycaemiaT2DPCOShypertensiondyslipidaemiaobesity
…s the effectiveness of a lifestyle digital therapeutic in three NHS Primary Care Networks (PCNs), to patients with T2D and NDH.Methods The intervention u…
NCT06140251heart failuresodium glucose co-transport (SGLT) 2 inhibitors
…SPSS Statistics, Version 28.0). Clinical Trials.gov identifier: NCT06140251.Results Forty-six patients were recruited with forty patients u…
ESCatrial fibrillationdeep sedation direct current cardioversionpharmacological cardioversion
…r-represented to-date, but with European Society of Cardiology (ESC) guidelines focusing more on patient-centred integrated care fo…
Irish Heart Foundationtype 2 diabetescardiovascular diseaseCVDchronic disease management programmehypertension
…e (CVD) through the chronic disease management programme to the Irish Heart Foundation’s behaviour change programme. This six-week, patient-centred he…
Southern Health and Social Care TrustTTEHF
…e (HF) care has undergone significant transformation within the Southern Health and Social Care Trust (SHSCT). However, there is no dedicated inpatient HF service. T…
ESCfurosemideAcute decompensated heart failure (ADHF)ADHF
…central to ADHF management. The European Society of Cardiology (ESC) guidelines for heart failure (HF) recommend starting IV furose…
ClinicalTrials.govperipheral artery diseaseEndovascular therapyHangzhou First People’s HospitalThrombectomy
…s and dissemination The RESOLVE clinical study is registered on ClinicalTrials.gov ( http://clinicaltrials.gov/). Ethical approval was granted by …
Hamas
… is slowly entering Gaza after the ceasefire between Israel and Hamas, but delivery “remains constrained,” humanitarian agencies have…
NCT04573166Fuwai HospitalHFpEFradiofrequency ablationCURB
…mes, safety and broader applicability.Trial registration number NCT04573166.…